![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0020.png)
WFSBP 2017
20
Scientific Programme Schedule /
Wednesday, 21 June 2017
Auditorium
15
Congress
Hall A3
Auditorium
12
Auditorium
10
Auditorium
11
B3 M1–M2 B3 M3–M4 Congress
Hall A1
8:30 S-43
Novel ap-
proaches in
mechanisms
of action of
antidepressant
treatment
S-44
Cannabinoid
Receptor (CBR)
gene variations
in neuropsy-
chiatric dis-
orders
FC-09
Depression 1
S-45
Behavioral
Addictions:
Diagnosis,
co-morbidity
and neuro-
biology
S-46
Neurobiology
and psycho-
pharmacology
of aggressive be-
haviour: Where
are we?
S-47
Catecolamines,
anhedonia and
depression
FC-10
Antipsychotics 2
9:00
9:30
10:00
Coffee Break
PL-03
Epigenetic
consequences of
early adversity
10:30
11:00
D-03
Deep brain
stimulation is
a worthwhile
treatment
method in
psychiatry
TFS-07
Enhancing the
role of primary
care in looking
after people
with mental
health problems
S-48
Pharmacoge-
netics of drug
defense and
neuroprotec-
tion: From the
Neandertal to
the modern
humans
S-49
Evidence-based
guidelines for
treatment of
major depres-
sive disorder:
Contrasting
views across the
world
S-50
Real time
assessment of
psychopatholo-
gy and behavior
in Bipolar Dis-
order (BP) using
e-mental health
technologies
WS-09
Schizophrenia
research in
Chile
11:30
12:00
12:30
13:00
WFSBP
General
Assembly
Guided
Poster Tours
P-11 – P-17
13:30
14:00
14:30
15:00 S-51
Advances in
biomarker
development
for neurostimu-
lation
TFS-08
Men's mental
health: Contem-
porary aspects
TFW-03
WFSBP Treat-
ment Guideline
Session: Do
bipolar mixed
states merit
a treatment
guideline on its
own?
S-52
The G protein
coupled recep-
tors as a target
for psychotropic
drugs
S-55
Rediscovering
Lithium
WS-10
Evidence for
brain stimula-
tion methods in
schizophrenia
S-53
Suicidal
behavior:
Neurobiological
and genetic
determinants
15:30
16:00
16:30
Coffee Break
17:00
FC-12
Schizophrenia
TFS-09
Providing acute
inpatient care
for children,
adolescents and
young adults
from a men’s
mental health
perspective
S-54
Lithium as a
neuroprotective
agent: When
and how?
FC-13
Genetics
FC-11
Inflammation
FC-14
Neuroimaging 2
FC-15
Addictive
disorders
17:30
18:00
18:30
Registration Counter
08:00–18:30
Poster Exhibition
09:00–17:00
Technical Exhibition
09:00–17:00